Our commitments towards patients
At GENFIT, our commitment to ethics and patient well-being is at the heart of every clinical trial we conduct. We prioritize transparency, respect, and collaboration, ensuring that patients are not only participants but true partners in advancing medical research. Through dedicated patient initiatives, we strive to empower individuals, uphold the highest ethical standards, and foster trust throughout every step of the clinical journey.
GENFIT’s Patient Advocacy Council initiatve is aimed to foster and nurture relationships with Patients Associations such as The Global Liver Institute (GLI®) and The European Liver Patient’s Association (ELPA), and facilite moments of connection between patients, pharma and physicians to gather key insights aimed to raise awareness and create safer and more effective clinical studies.
We maintain transparency in our clinical trial processes, from the initial design to the reporting of results. All our studies are registered in public databases, and we share our findings openly to contribute to the broader medical community’s knowledge.
Every clinical trial we conduct is reviewed and approved by independent ethics committees and regulatory authorities. These reviews ensure that our studies adhere to strict ethical guidelines and that the rights and safety of participants are protected at all times.
We prioritize informed consent, ensuring that all participants fully understand the nature of the trial, its potential risks, and benefits. Participation in our trials is entirely voluntary, and participants can withdraw at any time without any consequences.
We uphold the highest standards of confidentiality and data protection. Participants’ personal information and medical data are kept secure and are only accessible to authorized personnel. We ensure that all data is used ethically and responsibly, respecting the privacy of our participants.
